PLUS THERAPEUTICS, Inc. Common Stock

PSTVNASDAQ • USD
ThemeHealthcare - Oncology›Radiopharmaceuticals & ADCs
5.41 USD
↘ 0.33 (5.83%)AT CLOSE (11:59 AM EDT)
5.25
↘ 0.17 (3.05%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
5.25
↘ 0.17 (3.05%)
🔴Market: CLOSED
Open?$5.60
High?$5.62
Low?$5.17
Prev. Close?$5.75
Volume?120.4K
Avg. Volume?146.2K
VWAP?$5.34
Rel. Volume?0.82x
Bid / Ask
Bid?$5.10 × 100
Ask?$5.31 × 3.8K
Spread?$0.21
Midpoint?$5.21
Valuation & Ratios
Market Cap?37.2M
Shares Out?6.9M
Float?167.2M
Float %?97.4%
P/E Ratio?N/A
P/B Ratio?3.11
EPS?-$2.31
Dividend?0.00%
Ex-Dividend?N/A

Shares of PLUS THERAPEUTICS, Inc. Common Stock (PSTV) are trading at $5.41. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Furthermore, PSTV is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Themes
Healthcare - Oncology›Radiopharmaceuticals & ADCsBiotech - Drug Development›Rare Disease Therapeutics
Employees
28
Market Cap
37.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.plustherapeutics.com
Listed
2000-11-16
Address
4200 MARATHON BLVD.
AUSTIN, TX 78756
Phone: 737.255.7194
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
23
Short Sent.?
76
Piotroski F-Score?2/9Weak
Altman Z-Score?-36.20Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.70%Low
Short Interest?1.2M
Days to Cover?9.2
Free Float167.2M
Avg Daily Volume125.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.27Strong
Quick Ratio?2.27Strong
Cash Ratio?0.38Low
Debt/Equity?0.06Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
54
3.11FAIR▾
P/S?
Peers
100
S&P
16
7.19HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.9CHEAP▾
EV/Sales?
Peers
100
S&P
22
6.73HIGH▾
Returns & Efficiency
ROE?
S&P
3
-132.9%WEAK▾
ROA?
S&P
3
-79.8%WEAK▾
Cash Flow & Enterprise
FCF?$-21723000
Enterprise Value?$34.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist